Oral DHA treatment increased the p/t GSK3β ratio (+approximately 47.28% AD vs. AD-DHA, p < 0.01; Figures 6G,H), suggesting decreased the enzyme activity of GSK3β in AD mice. The gene discussed is GSK3B; the disease is Alzheimer disease.